David Katz - Matrix Asset Advisors
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    105
Portfolio value:    $1,090,209,468
Holdings Activity Buys Sells    History
Holding/activity history for  Human Genome Therapeutics (HGSI)
← All HGSI superinvestors
Period Shares % of Portfolio Activity % Change to Portfolio Price Value Filing
2003   Q1 0 0.00 Sell 100.00% 0.11 SEC
2002   Q4 77,240 0.11 Buy 0.11 $8.80 $680,000 SEC